comparemela.com
Home
Live Updates
Theriva biologics full year
Live Breaking News & Updates on Theriva Biologics Full Year
Stay updated with breaking news from Theriva biologics full year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript
Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc. ....
United States
,
Steven Shallcross
,
Theriva Biologics
,
Manel Cascallo
,
Chris Calabrese
,
Vince Wacher
,
James Molloy
,
Alliance Global Partners
,
Washington University
,
Product Development Of Theriva Biologics
,
University Of Pennsylvania
,
Albumin Shield Technology
,
Theriva Biologics Inc
,
Exchange Commission
,
Society For Immunotherapy Of Cancer Annual Meeting
,
Data Monitoring Committee
,
Call Transcript March
,
Theriva Biologics Full Year
,
Chief Executive
,
Chief Financial Officer
,
General Director
,
Product Development
,
Pancreatic Ductal Adenocarcinoma
,
Independent Data Monitoring Committee
,
South America
,
Sant Joan
,